Glotin Duo Tablets 2.5/500 Mg (linagliptin | Metformin Hydrochloride)
Recall Summary Glotindue Tablet 2.5/500mg (containing linagliptin and metformin hydrochloride), a diabetes medication distributed in South Korea, is being recalled because testing found the impurity N-nitroso-meglumine at levels exceeding the allowed limit. This recall affects all batches of this product with barcodes 8806625045509 and 8806625045516.
- Recalling firm
- Nexpharm Korea Co., Ltd.
- Product
- 글로틴듀오정2.5/500mg(리나글립틴|메트포르민염산염) (Barcode: 8806625045509, 8806625045516)
- Reason
- Detection of an impurity (N-nitroso-meglumine) exceeding the permissible limit
- Classification
- Class II
- Category
- drug recall
- Country
- South Korea
- Agency
- MFDS-DRUG
- Recall date
- 2026-06-24
- Status
- Ongoing
- Distribution
- South Korea
Official recall notice from MFDS-DRUG
Recall details on Nibble Recalls: https://trynibble.app/recalls/bf5a3365-95ed-49cb-a775-41f90ca84ce5